Insider Transactions in Q3 2022 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2022
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,479
-0.28%
|
$17,395
$5.25 P/Share
|
|
Aug 31
2022
|
Stephen Mitchener SVP, Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+22.09%
|
-
|
|
Aug 31
2022
|
Michael Mano SVP, General Counsel&Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+19.42%
|
-
|
|
Aug 31
2022
|
Michael Mason EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+15.11%
|
-
|
|
Aug 31
2022
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+20.01%
|
-
|
|
Aug 11
2022
|
Barry E Greene |
BUY
Exercise of conversion of derivative security
|
Direct |
7,576
+35.77%
|
$7,576
$1.49 P/Share
|
|
Aug 04
2022
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
2,314
-0.37%
|
$9,256
$4.48 P/Share
|
|
Jul 08
2022
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
2,115
-0.34%
|
$10,575
$5.18 P/Share
|